Clinical Trials

Phase EARLY_PHASE1 Not yet recruiting

682 enrolled

Neoplastic Cells, Circulating, Neoplasms

NCT06557096 2024-08-16

CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC

100 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT01619111 2024-06-04

DETECT III

Phase 3 Completed

105 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT02035813 2024-06-04

DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

Phase 2 Completed

116 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT03340844 2024-05-14

CETUPANC

86 enrolled

Neoplastic Cells, Circulating, Neoplasm Metastasis, Pancreatic Neoplasms

NCT06391892 2024-04-30

LIQUIPANC

Phase 3 Recruiting

100 enrolled

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT06262386 2024-02-16

Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial

Phase NA Recruiting

358 enrolled

Lung Neoplasms, Neoplastic Cells, Circulating, Recurrence

NCT05947188 2024-02-05

CMNDPC

808 enrolled

Disease, Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT02608346 2024-01-31

Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)

Phase EARLY_PHASE1 Completed

200 enrolled

Neoplastic Cells, Circulating

NCT03928210 2023-12-13

Digoxin Induced Dissolution of CTC Clusters

58 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT03700411 2023-12-07

POACC-1

Phase 4 Completed

125 enrolled

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT03700541 2023-12-07

POACC-2

Phase 4 Completed

71 enrolled

Phase 2 Not yet recruiting

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT05637567 2023-11-13

ASAP

170 enrolled

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT04648189 2023-10-19

Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC

Phase 2 Withdrawn

Lung Neoplasms, Neoplastic Cells, Circulating

NCT06090214 2023-10-19

BLADE

42 enrolled

Adenocarcinoma, Neoplastic Cells, Circulating

NCT04021459 2023-10-03

E-CTC

15 enrolled

Gynecologic

Neoplastic Cells, Circulating, Endometrial Neoplasms

NCT05964153 2023-08-30

Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients

10 enrolled

CNS

Glioma, Neoplastic Cells, Circulating

NCT05824299 2023-08-09

Influence of Anesthesia Methods on CTCs in TURBT Patients

162 enrolled

Urinary Bladder Neoplasms, Neoplastic Cells, Circulating

NCT05815082 2023-04-18

ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer

Phase 3 Recruiting

490 enrolled

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT05797077 2023-04-04

Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA

Phase 3 Recruiting

346 enrolled

Neoplastic Cells, Circulating, Colorectal Neoplasms, Neoplasms, Second Primary

NCT04601961 2023-03-31

Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients

220 enrolled

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating

NCT02849041 2023-03-07

DETeCTOR

176 enrolled

Neoplastic Cells, Circulating, Neoplasms

NCT04168931 2023-01-17

GASTHER2

Phase 2 Terminated

5 enrolled

Neoplastic Cells, Circulating, Stomach Neoplasms

NCT05070637 2022-11-14

CITO-CERENE

44 enrolled

Carcinoma, Renal Cell, Neoplastic Cells, Circulating

NCT05502458 2022-08-16

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

Phase 2 Completed

60 enrolled

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating

NCT03700437 2022-05-12

Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC)

12 enrolled

Carcinoma, Non-Small-Cell Lung, Fasting, Lung Neoplasms, Neoplastic Cells, Circulating

NCT03732339 2022-04-29

CTCNeoBC

29 enrolled

Neoplastic Cells, Circulating

NCT04475705 2022-03-16

Propofol vs Sevo for Paediatric Tumor Surgery

Phase 4 Recruiting

100 enrolled

Carcinoma, Neoplastic Cells, Circulating, Neoplasms

NCT03101046 2022-02-10

TACTIK

Phase 2 Completed

40 enrolled